Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc. (Lotus) is engaged in the development, manufacture and distribution of prescription drugs and pharmaceutical products. It operates and has ownership interests in Liang Fang Pharmaceutical, Ltd. (Liang) and En Zhe Jia Shi Pharmaceutical, Ltd. (En Zhe). Liang and En Zhe are collectively refereed as Lotus East and are together engaged in the production, trade, sales and marketing of pharmaceuticals. In China, both companies possess some of the most advanced pharmaceutical-production equipment. The company owns and operates 10 drug stores in Beijing, China, engaged in the sale of western and traditional Chinese medications, lease medical treatment facilities. Its current drug development pipeline has major focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The company is headquartered at Beijing, China.

Street: 
16 Cheng Zhuang Road
City: 
Beijing
Postcode: 
100071
Federal State : 
China
WebSite: 
www.lotuspharma.com
Fax: 
86-10-63899867

Company Index Score

Current Index Score Historical Index Score
  • Lotus Pharmaceuticals, Inc. currently scores 50 % in the index.
  • Lotus Pharmaceuticals, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Lotus Pharmaceuticals, Inc. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets